Mirvetuximab Soravtansine-Gynx Injection

33 interactions 20 cited references

Also sold as: Elahere Elahere®

About Mirvetuximab Soravtansine-Gynx Injection

Mirvetuximab soravtansine-gynx injection is used to treat certain types of ovarian (female reproductive organs where eggs are formed), fallopian tube (tube that transports eggs released by the ovaries to the uterus), and peritoneal (layer of tissue that lines the abdomen) cancer in people who have completely responded… Read the full Mirvetuximab Soravtansine-Gynx Injection drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 10, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Yellow Fever Vaccine Smallpox Monkeypox Vaccine Bacillus Of Calmette And Guerin Vaccine, Live Rubella Virus Vaccine, Live Mumps Virus Vaccine, Live Measles Virus Vaccine, Live

9 Contraindicated 24 Major

All (33) Contraindicated (9) Major (24)

Contraindicated

Mirvetuximab Soravtansine-Gynx Injection Bacillus Of Calmette And Guerin Vaccine, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Dengue Tetravalent Vaccine, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Measles Virus Vaccine, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Mumps Virus Vaccine, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Rubella Virus Vaccine, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Smallpox Monkeypox Vaccine An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Typhoid Vaccine Typhim VI® An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Varicella Virus Vaccine, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Yellow Fever Vaccine Stamaril An increased risk of infection by the live vaccine Details

Major

Mirvetuximab Soravtansine-Gynx Injection Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Boceprevir Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Clarithromycin Biaxin Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Cobicistat Tybost Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Conivaptan Vaprisol Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Idelalisib Zydelig Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Indinavir Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Influenza Virus Vaccine, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Itraconazole Sporanox Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Ketoconazole Extina Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Lopinavir Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Nefazodone Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Nelfinavir Viracept Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Posaconazole Noxafil Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Ribociclib Kisqali Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Ritonavir Norvir Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Rotavirus Vaccine, Live An increased risk of infection by the live vaccine Details Mirvetuximab Soravtansine-Gynx Injection Saquinavir Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Telaprevir Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Telithromycin Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details Mirvetuximab Soravtansine-Gynx Injection Voriconazole Vfend Increased unconjugated DM4 exposure and an increased risk of mirvetuximab soravtansine-gynx adverse reactions Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.